Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

Clinical trial NCT03488667 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03488667
Sponsor: University of Kansas Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastro Esophageal Junction Cancer Stomach Cancer Adenocarcinoma

Start date: 2018-06-27
Primary completion: 2024-04-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.